TECLens, Inc.

About TECLens, Inc.

TECLens is dedicated to restoring vision and improving quality of life for millions worldwide through innovative vision correction technologies. Their mission focuses on developing non-invasive, comfortable treatments to address various eye conditions, starting with presbyopia, and expanding to other vision impairments.

Products & Services

Quantitative Corneal Cross-Linking (qCXL™) Technology:A technology using ultraviolet light to strengthen and reshape the cornea, targeting presbyopia with comfortable, non-invasive, in-office treatments.

CXLens® Device:A device that works with qCXL™ technology to reshape the cornea, offering personalized precision planning and real-time ultrasound monitoring for vision correction.

Specialties

Vision Correction Corneal Cross-Linking Presbyopia Treatment Refractive Care Eye Care Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 9300000 MR: - FA: 9.3 million FAN: 9300000	D: 2025-02-11 FD: 2025-02-11	4 investors

Series A Latest

2025-02-11

$9.3M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tom Dunlap

CEO

P

Patrick Lopath

COO

P

Patrick D. Lopath

Chief Operating Officer

D

David E. Acker, ScD

Cofounder

H

Hirak Parikh, Ph.D.

H

Hirak Parikh, Ph.D

Principal, Investments Team at JJDC

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

TECLens, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised